In the News
SUNBEDS (UV TANNING BEDS), AND UV RADIATION MOVED UP TO HIGHEST CANCER RISK CATEGORY BY INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC)
Tuesday, July 28, 2009
THE LANCET ONCOLOGY: Press Release EMBARGO: 1830H (New York time) Tuesday 28 July 2009 PLEASE NOTE: THESE ARE LANCET ONCOLOGY RELEASES, PLEASE ENSURE YOU CREDIT THE LANCET ONCOLOGY IF USING THIS MATERIAL · IS PAPERWORK SUFFOCATING BRITISH CLINICAL RESEARCH? SUNBEDS (UV TANNING BEDS), AND UV RADIATION MOVED UP TO HIGHEST CANCER RISK CATEGORY BY INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC) The International Agency for Research on Cancer (IARC) has moved sunbeds (UV tanning beds) up to the highest cancer risk category—group 1—‘carcinogenic to humans’.… continue reading
Banning teens from tan beds
Tuesday, July 28, 2009
Lesley Young, Metro Vancouver
Using tanning beds before age 35 can increase a person’s risk of melanoma by an incredible 75 per cent, according to a review of studies on UVR exposure The younger someone gets a first suntan or burn, the greater the risk of developing skin cancer later in life.… continue reading
Health agency to test link between flu, vitamin D
Monday, July 27, 2009
Martin Mittelstaedt
In an effort to discover new ways to fight the swine flu, the Public Health Agency of Canada intends to test the blood of people contracting the ailment to check their vitamin D levels. The agency is taking the unconventional action to try to find out whether those with mild cases of the flu have more of the sunshine vitamin circulating in their bodies than those who develop severe or even deadly reactions to the H1N1 virus.… continue reading
Milk it for all it’s worth
Monday, July 27, 2009
By DOCTOR GIFFORD-JONES Toronto Sun
How many of us are not taking calcium supplements today? Not many if my patients are a good sample of what’s happening. But do you know that calcium supplementation may cause an increased number of hip fractures?… continue reading
Efavirenz, Race Linked to Vitamin D Deficiency
Friday, July 24, 2009
By David Evans
People on a regimen containing efavirenz (Sustiva or Atripla) had a higher risk of having low vitamin D levels—which can lead to bone problems—than people on a protease inhibitor regimen. The study, which also found race and season of the year to play a role in vitamin D levels, was presented at the Fifth International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town.… continue reading
